Editorial
doi: 10.3390/diagnostics11050908.
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
Affiliations
- PMID: 34069669
- PMCID: PMC8161324
- DOI: 10.3390/diagnostics11050908
Item in Clipboard
Editorial
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
Diagnostics (Basel).
.
Abstract
Prostate cancer (PCa) is the second most common neoplasm in men and the fifth leading cause of death worldwide [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide.Eur Urol. 2018 Aug;74(2):218-225. doi: 10.1016/j.eururo.2018.01.035. Epub 2018 Feb 10. Eur Urol. 2018. PMID: 29439820 Free PMC article.
-
Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.Eur Urol Oncol. 2020 Jun;3(3):291-297. doi: 10.1016/j.euo.2019.06.010. Epub 2019 Jul 3. Eur Urol Oncol. 2020. PMID: 31278035
-
Imaging-based prostate cancer screening among BRCA mutation carriers-results from the first round of screening.Ann Oncol. 2020 Nov;31(11):1545-1552. doi: 10.1016/j.annonc.2020.06.025. Epub 2020 Sep 18. Ann Oncol. 2020. PMID: 32958357
-
[Risk-adapted prostate cancer screening-update 2021].Urologe A. 2021 May;60(5):592-601. doi: 10.1007/s00120-021-01505-9. Epub 2021 Apr 1. Urologe A. 2021. PMID: 33792743 Review. German.
-
Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.Front Oncol. 2018 Feb 5;8:16. doi: 10.3389/fonc.2018.00016. eCollection 2018. Front Oncol. 2018. PMID: 29459887 Free PMC article. Review.
Cited by
-
Cytoreductive prostatectomy improves survival outcomes in patients with oligometastases: a systematic meta-analysis.World J Surg Oncol. 2022 Aug 9;20(1):255. doi: 10.1186/s12957-022-02715-x. World J Surg Oncol. 2022. PMID: 35945562 Free PMC article.
-
Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation.Diagnostics (Basel). 2023 Apr 1;13(7):1318. doi: 10.3390/diagnostics13071318. Diagnostics (Basel). 2023. PMID: 37046536 Free PMC article.
-
Germline mutations in 5' to c.7914 of BRCA2 significantly increase risk of prostate cancer.Asian J Androl. 2023 May-Jun;25(3):433-434. doi: 10.4103/aja202277. Asian J Androl. 2023. PMID: 36308075 Free PMC article. No abstract available.
-
Discovery of a Novel Bloom's Syndrome Protein (BLM) Inhibitor Suppressing Growth and Metastasis of Prostate Cancer.Int J Mol Sci. 2022 Nov 26;23(23):14798. doi: 10.3390/ijms232314798. Int J Mol Sci. 2022. PMID: 36499126 Free PMC article.
-
The direct prognosis comparison of 125I low-dose-rate brachytherapy versus laparoscopic radical prostatectomy for patients with intermediate-risk prostate cancer.Eur J Med Res. 2023 Jun 2;28(1):181. doi: 10.1186/s40001-023-01140-4. Eur J Med Res. 2023. PMID: 37268989 Free PMC article. Review.
References
-
- Ferro M., Lucarelli G., Crocetto F., Dolce P., Verde A., La Civita E., Zappavigna S., de Cobelli O., Di Lorenzo G., Facchini B.A., et al. First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings. Crit. Rev. Oncol. 2021;157:103198. doi: 10.1016/j.critrevonc.2020.103198. - DOI - PubMed
-
- Buonerba C., Matteo M., Dolce P., Felice C., Verde A., Giuseppe L., Luca S., Sergio F., Angelo V., Alfredo M., et al. Predictors of efficacy of androgen-receptor-axis-targeted therapies in patients with metastatic castration-sensitive prostate cancer: A systematic review and meta-analysis. Crit. Rev. Oncol. 2020;151:102992. doi: 10.1016/j.critrevonc.2020.102992. - DOI - PubMed
-
- Tedaldi G., Tebaldi M., Zampiga V., Cangini I., Pirini F., Ferracci E., Danesi R., Arcangeli V., Ravegnani M., Martinelli G., et al. Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients. Diagnostics. 2020;10:269. doi: 10.3390/diagnostics10050269. - DOI - PMC - PubMed
